NEW YORK (GenomeWeb News) - The US Food and Drug Administration’s regulatory approach toward laboratory-developed tests unfairly favors some manufacturers, and this imbalance was not sufficiently discussed during a recent meeting of the HHS Secretary’s Advisory Committee for Genetics, Health, and Society, according to Kathy Hudson, director of Johns Hopkins University’s Genetic Public Policy Center.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.